Search

everythinglearnresearchcommunity

for

Search:↓

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

SHBG may be a useful early indicator and treatment target for PCOS.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

High levels of androgens during early development may cause PCOS-like symptoms.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

CD146 + mesenchymal stem cells are more effective for treating premature ovarian failure.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Finasteride exposure harms tadpole reproduction and hormone balance.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Women with PCOS have lower zinc levels.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.